Retrospective analysis of nontraumatic subdural hematoma incidence and outcomes in Egyptian patients with end-stage renal disease on hemodialysis

Bibliographic Information
Authors: Fayed A.; Tarek A.; Refaat M.I.; Abouzeid S.; Salim S.A.; Zsom L.; Fülöp T.; Soliman K.M.; Elmallawany M.A.
Journal: Renal Failure
Publisher: Taylor and Francis Ltd.
Publication Date: 22 September 2021
Volume / Issue: Volume 43 / Issue 1
Pages: 1322–1328
ISSN: 0886022X
DOI: 10.1080/0886022X.2021.1979038
Scopus: View on Scopus
PubMed: 34547969
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Fayed A., Nephrology Unit, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt; Tarek A., Neurosurgery Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt; Refaat M.I., Neurosurgery Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt; Abouzeid S., Nephrology Department, Theodor Bilharz Research Institute, Cairo, Egypt; Salim S.A., Department of Medicine, Division of Nephrology, University of Mississippi Medical Center, Jackson, MS, United States; Zsom L., Fresenius Medical Care Hungary, Cegléd, Hungary; Fülöp T., Department of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, SC, United States, Medical Services, Ralph H. Johnson VA Medical Center, Charleston, SC, United States; Soliman K.M., Department of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, SC, United States, Department of Surgery, Transplant Nephrology, Medical University of South Carolina, Charleston, SC, United States; Elmallawany M.A., Neurosurgery Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt
Abstract
Background: The incidence of subdural hematoma (SDH) in chronic maintenance hemodialysis (CMH) patients may change over time, along with the evolving characteristics of the underlying populations. Methods: We conducted a retrospective, single-center study at Cairo University hospitals, assessing the incidence, associated risk factors, and outcomes of nontraumatic SDH in CMH patients between January 2006 and January 2019. Results: Out of 1217 CMH patients, nontraumatic SDH was diagnosed in 41 (3.37%) during the study, increasing with the enrollees’ age but stable over the observation period and translating into an annual incidence rate of 28 per 1000 patients per year. SDH patients were likely to use central venous catheters, reported pruritis and history of bone fractures, and had higher phosphorus, parathyroid hormone, and alkaline phosphatase values (p < 0.001); however, there was no association with atrial fibrillation or use of anticoagulants. In the SDH cohort (n = 41), six patients did not need surgical intervention and 13 patients died before becoming surgically fit for intervention; mortality correlated with ischemic heart disease (p = 0.033) and the presence of atrial fibrillation or chronic anticoagulation with warfarin (p < 0.0001 for both), among others. Twenty-two patients received surgical operations and of these 2 died postoperatively; overall patient mortality was 12/41 (29.27%) at 30 days and 15/41 (36.59%) at 1 year. Conclusion: Our study demonstrated a striking enrichment for underlying comorbidities in those patients developing SDH and a high risk of immediate mortality. The benefit of chronic anticoagulation therapy should be carefully weighed against the risk of CNS bleed in MHD patients. © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Keywords
Hemodialysis; mortality; nontraumatic subdural hematoma; outcome; Aged; Anticoagulants; Atrial Fibrillation; Egypt; Female; Hematoma, Subdural; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Risk Factors; acetylsalicylic acid; albumin; alkaline phosphatase; calcium; clopidogrel; ferritin; fibrinogen; hemoglobin; parathyroid hormone; phosphorus; uric acid; warfarin; anticoagulant agent; adult; age; albumin blood level; alkaline phosphatase blood level; anticoagulant therapy; Article; calcium blood level; clinical feature; clinical outcome; cohort analysis; comorbidity; controlled study; Egyptian; end stage renal disease; ferritin blood level; fibrinogen blood level; fracture; hemodialysis patient; hemoglobin blood level; human; maintenance therapy; major clinical study; medical history; observational study; parathyroid hormone blood level; phosphate blood level; platelet count; pruritus; retrospective study; risk factor; subdural hematoma; uric acid blood level; adverse event; chronic kidney failure
Citation Information
Scopus Citations: 5
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
